Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Non-Small Cell Lung Cancer
Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Non-Small Cell Lung Cancer
Proceedings from a CME symposium held during the 2017 IASLC Chicago Multidisclinary Symposium in Thoracic Oncology. Featuring perspectives from Drs Nasser H Hanna, Leora Horn, Corey J Langer and Lecia V Sequist.
1.75 AMA PRA Category 1 Credits™
To complete the Post-test and Educational Assessment and Credit Form, click here. A statement of CME credit will be issued for scores of 80% or better. Your statement of credit will be mailed to you within 3 weeks or may be printed online.
|